Navigation Links
Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
Date:3/4/2008

CARMEL, Ind., March 4 /PRNewswire-FirstCall/ -- In a filing with the SEC yesterday, Conseco, Inc. (NYSE: CNO), formally extended the due date of its Annual Report on Form 10-K to March 17, 2008. In the Form 12b-25 filing, the Company said it has not yet finalized its December 31, 2007 financial statements and is completing several items, including its analysis to determine the possible need to increase the deferred income tax asset valuation allowance. Conseco estimated that its net income (loss) for the three months ended December 31, 2007 will be approximately breakeven, including estimated net realized investment losses (after related amortization and taxes) of $25 million, but before any adjustments which may result from finalizing the incomplete items.

The Company also reported in its Form 12b-25 filing that it has been consulting with the staff of the SEC's Office of the Chief Accountant (the "SEC Staff") regarding its accounting policy for long-term care premium rate increases as described in the Summary of Significant Accounting Policies in its 2006 Form 10-K. On February 28, 2008, the SEC Staff informed Conseco of their view that the use of a method which prospectively changes reserve assumptions for long-term care policies based solely on changes in premium rates is not consistent with the guidance of Statement of Financial Accounting Standards No. 60, "Accounting and Reporting by Insurance Enterprises." The Company is continuing to evaluate the SEC Staff's view and has reflected the estimated effect in the estimated net income (loss) provided above.

As a result of these developments, the Company will report results for the fourth quarter of 2007 before the market opens on Monday, March 17 and will host its quarterl
'/>"/>

SOURCE Conseco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Hacker Joins Conseco as Senior Vice President and Treasurer
2. Tongson Joins Conseco as Senior Vice President, Corporate Actuarial
3. Conseco to Implement Systems and Operational Solution From Long Term Care Group
4. Conseco Reports Third Quarter Results
5. Conseco Sets Earnings Release Date
6. Conseco Completes Divestiture of Old Block of Fixed and Equity-Indexed Annuities
7. Barta joins Conseco as Senior Vice President, Financial Planning & Analysis; Barra named Senior Vice President, Internal Audit; Clarke to head Investor Relations
8. Conseco to Host Follow-Up Long-Term Care Conference Call
9. RealSelf.com Denies Lifestyle Lifts Trademark Claims and Files Countersuit
10. Novo Nordisk Files Annual Report with the SEC
11. PLC Systems Files IDE Supplement to Begin Pivotal Study of RenalGuard(TM) and Provides Update on Planned Development Timeline

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...O A large proportion of patients who undergo abdo...dicated and unnecessary additional image acquisiti...re, according to a study presented today at the an...America (RSNA). , "It is the responsibility of a...ensure that the dosage is as low as reasonably ach...
(Date:11/29/2009)..., ATLANTA, Nov. 29 The followin...livest Securities Research, Inc. ,, Intellivest...stered investment advisor, has published a Report ... in the pharmaceutical, biotechnology and medical ...heir clients manage, process and submit medical im...
(Date:11/29/2009)...ng someone get blamed for something leads to more ... , SUNDAY, Nov. 29 (HealthDay News) -- The bl... even when the target is innocent. , Researcher... else for a problem, even if it,s an unfair accusa...g others, too. , "When we see others protectin...
(Date:11/28/2009)... , CHICAGO, Nov. 28 Welcome to...solution for the clinical routine from Siemens H...Communications System (PACS) from Siemens where ... syngo .plaza is poised to change the way mul...ling this innovation at the 95th Scientific Asse...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall...any"), a supplier of precision technology products...n annual meeting of the Company,s shareholders has...ime and location of the meeting will be announced ...ny received a requisition notice from Stephen Bers...
Breaking Medicine News(10 mins):Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:Research Report on BioClinica, Inc. as Speculative Buy 2Health News:When Accusations Start to Fly, They Multiply 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2
...fering from Insomnia , , LOS ANGELES, March 31 F...ng and negative impact than a lost night,s sleep. ...nd the endless array of other daily responsibiliti...nfortunately, many women are doing just that, and ...
...vides Extensive Services & Support , , SAN FR...xperienced provider of in home support and recover... its San Francisco location. Interim HomeStyle Se...r from illness. , , The San Francisco location w...
... top, industry employers across North Carolina , ...h 31, 2009 -- BioSpace , the leading resource for...e seventh edition of the Bio NC Hotbed Campaign ...Research Triangle Park and other areas of North Ca...
...FACP is in the private practice of internal medici... the best doctors in New Jersey by New Jersey Mont...;Top Doctor" accolade for the third consecuti... year in the November, 2008 issue of New Jersey Mo...
...laxoSmithKline plc (NYSE: GSK ) has entered into..., Nasdaq: SHPGY ) for Vy v a n s e(R) , to...lt Attention Deficit Hyperactivity Disorder (ADHD)...in discovering and developing medicines to treat p...
...nuts sold in at least 31 states , , MONDAY...Administration officials said Monday night that th...on that could involve 1 million pounds of pistachi... said. , "We are not dealing with an outbreak here...
Other Medicine News:Health News:Tired of Sleepless Nights? 2Health News:Nation's Largest Home Care Provider Welcomes New Management Team to San Francisco Office 2Health News:BioSpace Launches the 2009 Bio NC™ Hotbed Campaign 2Health News:Dr Howard Holtz Named New Jersey Top Doctor for Third Consecutive Year 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 2Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 3Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 4Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 5Health News:GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder 6Health News:FDA Investigating Salmonella-Tainted Pistachios 2
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-Fir...hat Dr. Michael J. McKelvey, the Company,s Preside...tive Vice President and CFO, are scheduled to pres...onference at 1:30 PM EST on December 1, 2009 in Ne...y access the presentation by visiting the Company,...
(Date:11/25/2009)... , BRIDGEWATER, N.J., Nov. 25 ...® (etravirine) tablets, a non-nucleoside reve...the only NNRTI specifically indicated for use in t...irologic failure with HIV-1 strains resistant to a...e traditional approval is based on 48-week data fr...
(Date:11/25/2009)... , RANCHO CORDOVA, Calif., Nov. 25 /PRNewswir... of American Pacific Corporation (Nasdaq: APFC ) ... Responsibility and Sustainability Award at the An...the California Manufacturers and Technology Associ...tion (IEA) and the Chemical Industry Council of Ca...
Breaking Medicine Technology:ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 1Chindex International Inc to Report Second Quarter Fiscal 2010 Financial Results 5675 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 1Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 2Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 3Dr Siegal 26apos 3Bs Cookie Diet Book by Obesity Expert Sanford Siegal D O M D Cracks Amazon Top 500 60049 4FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 1FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 2FDA Determines VYVANSE 28R 29 was Properly Granted Five Year Market Exclusivity 5672 3
...26 The Blumenthal,Cancer Center at Carolinas Medi...he Moffitt Cancer Center in a study that could lea...of cancer. CMC is the first hospital system,outsid... Over the next five years, CMC will enroll more t...e collecting tissue samples, medical histories,and...
...26 Pharmacopeia,(Nasdaq: PCOP ), an innovator in...cule therapeutics, today announced the completion ... 2a clinical study of PS433540 (DARA),the company,...f the Phase,2a randomized, double-blind, placebo-c... efficacy and safety of 200 and 500 mg of PS433540...
Other Medicine Technology:CMC, Moffitt Partner to Study Cancer 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Completes Enrollment in Phase 2 Hypertension Study with PS433540 (DARA) 4
ABL800 FLEX Blood Gas Analyzer
Flatbed Agitator PFS84
Flatbed Agitator PFS42
...telet agitators offer a wide range of storage capa... storage platform to agitate smoothly, eliminating...ueak. Sturdy, one-piece perforated drawers with no...ation for your platelets., ,i.Series platelet ...
Medicine Products: